Search Browse Earnings

Q32 Bio Inc. — SlamSEC

Q32 Bio Inc.

Nasdaq:QTTB

Pharmaceutical Preparations·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$3.2M

-90.6% YoY

FY 2023

Adj. EBITDA

-$65.6M

-2045.4% margin

FY 2025

Net Income

-$47.7M

-1487.9% margin

FY 2025

EPS (Diluted)

-$6.58

FY 2025

Stock Price

$6.30

-7.6%

2026-03-16

52W Range

$1.34 – $7.80

P/E Ratio

-1.0x

Market Cap

$92.2M

Cash

$78.0M

FY 2025

Total Debt

—

Net Cash

$78.0M

FY 2023

Enterprise Value

$14.2M

Debt / EBITDA

1.2x

FY 2023

EV / EBITDA

-0.2x

Employees

—